KEVIN CAMPBELL: Open Payments
NPI 1477933976 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$154 in 7 payments from 5 companies in 2025. Trend: 2023 $174 · 2024 $344 · 2025 $154
Food & beverage: $154
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $42 |
| Lilly USA, LLC | 1 | $26 |
| Abbott Laboratories | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: Ozempic, FANAPT, KISUNLA, FREESTYLE LIBRE 3, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
